Dallas, Texas. The Alliance for NanoHealth Science Summit will be hosted by the highly renowned Dr. Mauro Ferrari, Professor of the Brown Institute of Molecular Medicine and Chairman of the Department of Biomedical Engineering at the University of Texas Health Science Center in Houston, Texas. As President of the Alliance for NanoHealth, Dr. Ferrari heads a team of medical professionals in nanotechnology to collaborate at nanoTX’07, the International Nanotechnology Conference and Trade Expo held at the Dallas Convention Center October 3-4, 2007.
Although four nanotechnology events are co-locating under one roof at nanoTX’07 (the others are AeroSpace/Defense, Semiconductor, and Energy/Environment), health science is rapidly being catapulted to the forefront of nanotechnology research. “If we could detect cancer early enough, the currently available therapies would be enough to treat essentially all cases,” Dr. Ferrari told reporters. And “Nanotechnology has the power to give us the required breakthrough advances in early detection.”
Dr. Ferrari served as the National Cancer Institute’s special expert on nanotechnology and shaped its long-term $144.3 Million Alliance for Nanotechnology in Cancer initiative, which is the world’s largest effort in nanomedicine. His BioMed/Health Science Summit is attracting groups as diverse as physicians, researchers, patients advocates, and business leaders with the purpose of accelerating the development of transformational approaches to early detection of disease and personalized therapy.
Indeed, titles of the two sessions to be hosted by Dr. Ferrari are: Nanotechnology for Medical Diagnostics, and Nanotechnology-Based Medical Therapeutics, delivering therapy at the right place and right time while avoiding many daunting biological barriers, bringing cures for heart disease, cancer, and other conditions. “Personalizing cancer therapy is not only a good idea, “ says Dr. Ferrari, “It is the only way to go to eradicate cancer death and suffering. Nanotechnology can provide revolutionary advances towards the personalization of treatment.”
A large number of nanotechnology related medical exhibits will surround the Summit in the BioMed/Health Science Pavilion. One commercial firm participating is Ceutical Labs. CEO Courtland Imel calls nanotechnology and drug delivery “the new frontier in medicine with development of next generation parenteral drug delivery and transdermal devices, not just development of oral drug delivery systems. Dr. Ferrari agreed, saying “nanotechnology will revolutionize the pharmaceutical industry.”
Mr. Imel will showcase current applications in the marketplace and demonstrate an overview of Ceutical Labs involvement in drug development and medical device applications.
Although presented by the Texas Nanotechnology Initiative, nanoTX’07 ( www.nanotx.biz ), is an international event with the theme: The Promise of Tomorrow—The Global Business of Nanotechnology.
CONTACT: Kelly Kordzik, Pres. Texas Nanotechnology Initiative, (512)226-8148
Arthur Carstairs, Deputy Press Officer, 214-513-9567
